TCT-69 A Randomized Comparison of The Second Generation Biodegradable Polymer Sirolimus-eluting Stent (EXCEL-II) and The First Generation EXCEL-I stent in Patients with De novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial
2016
First-in-man study has demonstrated promising feasibility, safety, and efficacy of the second generation biodegradable polymer sirolimus-eluting stent (EXCEL II), with thin cobalt-chromium struts and less sirolimus loading, in the treatment of patients with de novo coronary lesions. This study was
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI